mycosis fungoides

Showing 51 - 58 of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin Lymphoma, Mycosis Fungoides Trial in Stanford (CPG 7909)

Completed
  • Non-Hodgkin Lymphoma
  • Mycosis Fungoides
  • CPG 7909
  • Stanford, California
    Stanford University School of Medicine
Jul 7, 2014

Mycosis Fungoides Trial in United States (mechlorethamine-MCH (nitrogen mustard))

Completed
  • Mycosis Fungoides
  • mechlorethamine-MCH (nitrogen mustard)
  • Stanford, California
  • +11 more
Oct 2, 2012

Mycosis Fungoides Trial in United States (0.04% Mechlorethamine gel)

Completed
  • Mycosis Fungoides
  • 0.04% Mechlorethamine gel
  • Stanford, California
  • +10 more
Aug 7, 2012

Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (HuMax-CD4 (zanolimumab))

Terminated
  • Mycosis Fungoides
  • Sezary Syndrome
  • HuMax-CD4 (zanolimumab)
  • Birmingham, Alabama
  • +34 more
Jul 24, 2012

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (ONTAK)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
  • Houston, Texas
  • +34 more
Feb 29, 2008

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (ONTAK)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
  • Houston, Texas
  • +33 more
Feb 29, 2008

Mycosis Fungoides Trial (Low-dose total skin electron beam therapy (4 Gy))

Terminated
  • Mycosis Fungoides
  • Low-dose total skin electron beam therapy (4 Gy)
  • (no location specified)
Jul 2, 2007

Mycosis Fungoides, Sezary Syndrome Trial in Lima (alemtuzumab)

Unknown status
  • Mycosis Fungoides
  • Sezary Syndrome
  • Lima, Peru
    Schering Peruana S.A.
Apr 2, 2007